BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10070128)

  • 1. Cardiovascular, endocrine, and renal effects of urodilatin in normal humans.
    Bestle MH; Olsen NV; Christensen P; Jensen BV; Bie P
    Am J Physiol; 1999 Mar; 276(3):R684-95. PubMed ID: 10070128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men.
    Saxenhofer H; Raselli A; Weidmann P; Forssmann WG; Bub A; Ferrari P; Shaw SG
    Am J Physiol; 1990 Nov; 259(5 Pt 2):F832-8. PubMed ID: 2146885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and action of urodilatin infusion in healthy volunteers.
    Carstens J; Jensen KT; Pedersen EB
    Clin Pharmacol Ther; 1998 Jul; 64(1):73-86. PubMed ID: 9695722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of continuous urodilatin infusion: a dose-finding study.
    Dorner GT; Selenko N; Kral T; Schmetterer L; Eichler HG; Wolzt M
    Clin Pharmacol Ther; 1998 Sep; 64(3):322-30. PubMed ID: 9757156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.
    Bidiville J; Waeber G; Porchet M; Nussberger J; Biollaz J; Gomez H; Callahan L; Waeber B; Brunner HR
    Fundam Clin Pharmacol; 1988; 2(5):413-29. PubMed ID: 2976727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs.
    Bestle MH; Bie P
    Acta Physiol Scand; 1993 Sep; 149(1):77-83. PubMed ID: 8237425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of urodilatin infusion on renal haemodynamics, tubular function and vasoactive hormones.
    Carstens J; Jensen KT; Pedersen EB
    Clin Sci (Lond); 1997 Apr; 92(4):397-407. PubMed ID: 9176040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of ANP with endothelin on cardiovascular, renal, and endocrine function.
    Ota K; Kimura T; Shoji M; Inoue M; Sato K; Ohta M; Yamamoto T; Tsunoda K; Abe K; Yoshinaga K
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E135-41. PubMed ID: 1531732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
    Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor.
    Carstens J; Pedersen EB
    Scand J Clin Lab Invest; 2008; 68(1):2-10. PubMed ID: 17852806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and systemic effects of urodilatin in rats with high-output heart failure.
    Abassi ZA; Powell JR; Golomb E; Keiser HR
    Am J Physiol; 1992 Apr; 262(4 Pt 2):F615-21. PubMed ID: 1533100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic and renal effects of urodilatin in healthy volunteers.
    Kentsch M; Ludwig D; Drummer C; Gerzer R; Müller-Esch G
    Eur J Clin Invest; 1992 May; 22(5):319-25. PubMed ID: 1317296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological responses to low dose infusions of atrial peptide in conscious dogs.
    Metzler CH; Keil LC; Ramsay DJ
    Life Sci; 1989; 44(14):935-43. PubMed ID: 2522576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine natriuresis in salt-repleted, water-loaded humans: a dose-response study.
    Olsen NV; Olsen MH; Bonde J; Kanstrup IL; Plum I; Strandgaard S; Leyssac PP
    Br J Clin Pharmacol; 1997 May; 43(5):509-20. PubMed ID: 9159566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure.
    Molina CR; Fowler MB; McCrory S; Peterson C; Myers BD; Schroeder JS; Murad F
    J Am Coll Cardiol; 1988 Jul; 12(1):175-86. PubMed ID: 2967855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure.
    Elsner D; Muders F; Müntze A; Kromer EP; Forssmann WG; Riegger GA
    Am Heart J; 1995 Apr; 129(4):766-73. PubMed ID: 7900630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
    Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of atrial natriuretic factor (99-126) in conscious sodium-replete sheep.
    Yates NA; McDougall JG; Coghlan JP; Coker AR; Gibson AP; Scoggins BA
    Clin Exp Pharmacol Physiol; 1988 Jul; 15(7):551-62. PubMed ID: 2978747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.